SCHEMBL2292899

SCHEMBL2292899

O=C(Oc1cc(Br)c(CBr)cc1OC(=O)c1ccccc1)c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 9/20 0.47
MAPT P10636 4/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
CA12 O43570 1/20 0.44
CA9 Q16790 1/20 0.44
ESR1 P03372 2/20 0.44
ESR2 Q92731 2/20 0.44
SLC6A3 Q01959 1/20 0.43
MEN1 O00255 4/20 0.42
JAK2 O60674 1/20 0.42
USP2 O75604 1/20 0.42
GAA P10253 1/20 0.42
ALOX15 P16050 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
HSD17B10 Q99714 1/20 0.42
TDP1 Q9NUW8 2/20 0.41
CES2 O00748 1/20 0.41
CES1 P23141 1/20 0.41
CYP3A4 P08684 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9340109 0.80 KMT2A (0.58) KMT2AMAPTSMN1; SMN2ESR1ESR2
SCHEMBL2291395 0.80 KMT2A (0.55) KMT2AMAPTCA12CA9MEN1
SCHEMBL4798869 0.78 CES2 (0.53) KMT2AMAPTSMN1; SMN2CA12CA9
SCHEMBL9339364 0.78 KMT2A (0.56) KMT2AMAPTSMN1; SMN2CA12CA9
SCHEMBL2295218 0.77 THRA (0.46) KMT2AMAPTSMN1; SMN2ESR1ESR2
SCHEMBL2288266 0.75 TNFSF11 (0.42) CA12CA9GAAALDH1A1
SCHEMBL14248985 0.74 KMT2A (0.63) KMT2AMAPTSMN1; SMN2ESR1ESR2
SCHEMBL8940387 0.74 KMT2A (0.62) KMT2AMAPTSMN1; SMN2CA12CA9
SCHEMBL3236453 0.73 HPGD (0.50) KMT2AMAPTSMN1; SMN2CA12CA9
SCHEMBL8198695 0.72 KMT2A (0.56) KMT2AMAPTSMN1; SMN2CA12CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2149545-B1 METHOD FOR PRODUCING BENZALDEHYDE COMPOUND SUMITOMO CHEMICAL CO (JP) 2016-10-05 EP disclosed
US-7994367-B2 Method for producing benzaldehyde compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-08-09 US disclosed
US-20100210879-A1 METHOD FOR PRODUCING BENZALDEHYDE COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-08-19 US disclosed
EP-2149545-A1 METHOD FOR PRODUCING BENZALDEHYDE COMPOUND Sumitomo Chemical Company, Limited (JP) 2010-02-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100210879-A1 METHOD FOR PRODUCING BENZALDEHYDE COMPOUND NQO1, C9, TRPA1 KMT2A 481/4885MAPT 3284/4885SMN1; SMN2 3093/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.